ERBB3 and cholangiocarcinoma: While erythroblastic leukemia viral oncogene homolog 3 (ErbB3) or vascular endothelial growth factor A (VEGFa) were predicted targets of miR-205, altered expression of ErbB3 and VEGFa was not observed upon overexpression of miR-205, suggesting that other target genes are involved in the regulation of gemcitabine sensitivity by miR-205 in CCA [65].